Planta Med 2013; 79(17): 1666-1673
DOI: 10.1055/s-0033-1350959
Pharmacokinetic Investigations
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Differences in Pharmacokinetics and Anti-inflammatory Effects between Decoction and Maceration of Sanhuang Xiexin Tang in Rats and Mice

Qian Zhang
1   The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China
2   Shanghai R&D Centre for Standardization of Chinese Medicines, Shanghai, China
,
Yue-ming Ma
3   Laboratory of Pharmacokinetics, Shanghai University of Traditional Chinese Medicine, Shanghai, China
,
Zheng-tao Wang
1   The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China
2   Shanghai R&D Centre for Standardization of Chinese Medicines, Shanghai, China
,
Chang-hong Wang
1   The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China
2   Shanghai R&D Centre for Standardization of Chinese Medicines, Shanghai, China
› Author Affiliations
Further Information

Publication History

received 02 August 2013
revised 18 September 2013

accepted 23 September 2013

Publication Date:
08 November 2013 (online)

Abstract

The pharmacokinetics and anti-inflammatory effects of Sanhuang Xiexin Tang, composed of Rhei Radix et Rhizoma, Scutellariae Radix, and Coptidis Rhizoma, prepared by decoction and maceration, were investigated and compared. Rats were orally administered with the decoction and maceration of Sanhuang Xiexin Tang at 30 g/kg. The concentrations of 10 active constituents (berberine, palmatine, jatrorrhizine, coptisine, wogonin, baicalin, wogonoside, emodin, aloe-emodin, and rhein) in plasma were determined by UPLC-MS/MS. Mice were orally administered decoctions and macerations of Sanhuang Xiexin Tang continuously for 7 days at three doses and stimulated with lipopolysaccharide. The plasma concentrations of IL-10 and TNF-α were determined by ELISA. Different preparation methods resulted in significant differences in the pharmacokinetic characteristics of the SXT constituents, especially the protoberberine alkaloids. Maceration decreased the absorption of flavones while promoting the absorption of anthraquinones. Bioavailability of both flavones and anthraquinones increased after administration of macerated Sanhuang Xiexin Tang, especially those of baicalin and rhein, which increased by 3.27 and 7.10 times. Results of ELISA indicated that both the decoction and maceration of Sanhuang Xiexin Tang could significantly increase IL-10 production (p < 0.01) as well as decrease TNF-α production (p < 0.01). Macerated Sanhuang Xiexin Tang has a slightly higher anti-inflammatory effect than the Sanhuang Xiexin Tang decoction. Different preparation methods affected the pharmacokinetic characteristics and anti-inflammatory effects of Sanhuang Xiexin Tangʼs active constituents.

Supporting Information

 
  • References

  • 1 Chen RC. Survey of Xiexin Tang categorized formulas. J Tradit Chin Med 2008; 7: 19-22
  • 2 Ma BL, Ma YM, Yan DM, Zhou H, Shi R, Wang TM, Yang Y, Wang CH, Zhang N. Effective constituents in Xiexin decoction for anti-inflammation. J Ethnopharmacol 2009; 125: 151-156
  • 3 Lo YC, Lin YL, Yu KL, Lai YH, Wu YC, Ann LM, Chen IJ. San-Huang-Xie-Xin-Tang attenuates inflammatory responses in lipopolysaccharide-exposed rat lungs. J Ethnopharmacol 2005; 101: 68-74
  • 4 Lo YC, Tsai PL, Huang YB, Shen KP, Tsai YH, Wu YC, Lai YH, Chen IJ. San-Huang-Xie-Xin-Tang reduces lipopolysaccharides-induced hypotension and inflammatory mediators. J Ethnopharmacol 2005; 96: 99-106
  • 5 Lee JC, Tseng CK, Wu SF, Chang FR, Chiu CC, Wu YC. San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression. J Viral Hepat 2011; 18: 315-324
  • 6 Liu BL, Xuan YY, Wang XH, Liu XH. Pharmacodynamic study of Sanhuang Xiexin Tan for treatment of upper gastrointestinal hemorrhage. Pharm Clin Chin Mater Med 2003; 19: 1-3
  • 7 Saegusa Y, Sugiyama A, Takahara A, Nagasawa Y, Hashimoto K. Relationship between phosphodiesterase inhibition induced by several Kampo medicines and smooth muscle relaxation of gastrointestinal tract tissues of rats. J Pharmacol Sci 2003; 93: 62-68
  • 8 Shih YT, Wu DC, Liu CM, Yang YC, Chen IJ, Lo YC. San-Huang-Xie-Xin-Tang inhibits Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells. J Ethnopharmacol 2007; 112: 537-544
  • 9 Li TK. Tentative study of solvent for decocting drug in treaties on cold damage diseases. Res Tradit Chin Med 1997; 1: 31-32
  • 10 Zan B, Shi R, Wang TM, Wu JS, Ma YM, Cheng NN. Simultaneous quantification of multiple active components from Xiexin decoction in rat plasma by LC-ESI-MS/MS: application in pharmacokinetics. Biomed Chromatogr 2011; 25: 816-826
  • 11 Shia CS, Hou YC, Juang SH, Tsai SY, Hsieh PH, Ho LC, Chao PD. Metabolism and pharmacokinetics of San-Huang-Xie-Xin-Tang, a polyphenol-rich Chinese medicine formula, in rats and ex-vivo antioxidant activity. Evid Based Complement Alternat Med 2011; 2011: 1-9
  • 12 Yan DM, Ma YM. Simultaneous quantification of five anthraquinones in rat plasma by high-performance liquid chromatography with fluorescence detection. Biomed Chromatogr 2007; 21: 502-507
  • 13 Ma YM, Yan JC, Wang TM, Shi R, Jiao YB. Anti-inflammatory effects of Xiexin decoction on animal models of acute inflammation. Chin Pharmacol Bull 2006; 22: 1393-1398
  • 14 Zhang Q, Wang CH, Ma YM, Zhu EY, Wang ZT. UPLC-ESI/MS determination of 17 active constituents in two categorized formulas of traditional Chinese medicine, Sanhuang Xiexin Tang and Fuzi Xiexin Tang: application in comparing with the difference in decoctions and macerations. Biomed Chromatogr 2013; 27: 1079-1088
  • 15 Sheng MP, Sun Q, Wang H. Studies on the intravenous pharmacokinetics and oral absorption of berberine HCI in beagle dogs. Chin Pharmacol Bull 1993; 9: 64-67
  • 16 Zeng X. Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomed Chromatogr 1999; 13: 442-444
  • 17 Yu S, Pang XY, Deng YX, Liu L, Liang Y, Liu XD, Xie L, Wang GJ, Wang XT. A sensitive and specific liquid chromatography mass spectrometry method for simultaneous determination of berberine, palmatine, coptisine, epiberberine and jatrorrhizine from Coptidis Rhizoma in rat plasma. Int J Mass Spectrom 2007; 268: 30-37
  • 18 Tsaia PL, Tsai TH. Simultaneous determination of berberine in rat blood, liver and bile using microdialysis coupled to high-performance liquid chromatography. J Chromatogr A 2002; 961: 125-130
  • 19 Ozaki Y, Suzuki H, Satake M. Comparative studies on concentration of berberine in plasma after oral administration of coptidis rhizoma extract, its cultured cells extract, and combined use of these extracts and glycyrrhizae radix extract in rats. Yakugaku Zasshi 1993; 113: 63-69
  • 20 Liu FQ, Li ZD, Shi XJ, Zhong MK. Determination of berberine, palmatine and jatrorrhizine in rabbit plasma by liquid chromatography-electrospray ionization-mass spectrometry. J Pharm Biomed Anal 2011; 56: 1006-1015
  • 21 Lu T, Liang Y, Song J, Xie L, Wang GJ, Liu XD. Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du decoction and the pharmacokinetic application of the method. J Pharm Biomed Anal 2006; 40: 1218-1224
  • 22 Yu S, Yu YL, Liu L, Wang XT, Lu SS, Liang Y, Liu XD, Xie L, Wang GJ. Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-gP involved?. Planta Med 2010; 76: 876-881
  • 23 Liu YT, Hao HP, Xie HG, Lai L, Wang Q, Liu CX, Wang GJ. Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab Dispos 2010; 38: 1779-1784
  • 24 Qiu W, Jiang XH, Liu CX, Ju Y, Jin JX. Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp. Phytother Res 2009; 23: 1553-1558
  • 25 Li Y, Ren G, Wang YX, Kong WJ, Yang P, Wang YM, Li YH, Yi H, Li ZR, Song DQ, Jiang JD. Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes. J Transl Med 2011; 9: 62-71
  • 26 Wang L, Ye XL, Li XG, Chen Z, Chen XD, Gao Y, Zhao ZQ, Huang WW, Yi J. Metabolism, transformation and distribution of Coptidis Rhizoma total alkaloids in rat. China J Chin Mater Med 2010; 35: 2017-2020
  • 27 Xing J, Chen XY, Zhong DF. Absorption and enterohepatic circulation of baicalin in rats. Life Sci 2005; 78: 140-146
  • 28 Plusquellec Y, Efthymiopoulos C, Duthil P, Houin G. A pharmacokinetic model for multiple sites discontinuous gastrointestinal absorption. Med Eng Phys 1999; 21: 525-532
  • 29 Tu XK, Yang WZ, Shi SS, Chen Y, Wang CH, Chen CM, Chen Z. Baicalin inhibits TLR2/4 signaling pathway in rat brain following permanent cerebral ischemia. Inflammation 2010; 34: 463-470
  • 30 Cong XD, Ding MJ, Dai DZ, Wu Y, Zhang Y, Dai Y. ER stress, P66shc, and P-Akt/Akt mediate adjuvant-induced inflammation, which is blunted by argirein, a supermolecule and rhein in rats. Inflammation 2011; 35: 1031-1040
  • 31 Lim HA, Lee EK, Kim JM, Park MH, Kim DH, Choi YJ, Ha YM, Yoon JH, Choi JS, Yu BP, Chung HY. PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney. Biogerontology 2011; 13: 133-145
  • 32 Martin G, Bogdanowicz P, Domagala F, Ficheux H, Pujol JP. Rhein inhibits interleukin-1β-induced activation of MEK/ERK pathway and DNA binding of NF-κB and AP-1 in chondrocytes cultured in hypoxia: a potential mechanism for its disease-modifying effect in osteoarthritis. Inflammation 2003; 27: 233-246
  • 33 Piao HZ, Jin SA, Chun HS, Lee JC, Kim WK. Neuroprotective effect of wogonin potential roles of inflammatory cytokines. Arch Pharm Res 2004; 27: 930-936
  • 34 Li Y, Xu X. The content condition of effective composition in Sanhuang Xiexin decoction. China J Chin Mater Med 2006; 31: 383-385
  • 35 Li CY, Hou YC, Chao PD, Shia CS, Hsu IC, Fang SH. Potential ex vivo immunomodulatory effects of San-Huang-Xie-Xin-Tang and its component herbs on mice and humans. J Ethnopharmacol 2010; 127: 292-298
  • 36 Ma BL, Ma YM, Yan DM, Zhou H, Shi R, Wang TM, Yang Y, Wang CH, Zhang N. Effective constituents in Xiexin decoction for anti-inflammation. J Ethnopharmacol 2009; 125: 151-156